Sema4 Appoints Isaac Ro, Life Sciences Executive and Wall Street Veteran, as Chief Financial Officer

STAMFORD, CT — February 8, 2021 — Sema4, a patient-centered health intelligence company, today announced the appointment of Isaac Ro as Chief Financial Officer (CFO). Mr. Ro brings 20 years of financial leadership and experience, with a strong focus on the medical technology and life sciences space. At Sema4, he will be responsible for leading all aspects of financial strategy, management, and planning.

Mr. Ro previously served as CFO of Thrive Earlier Detection Corp., a company dedicated to incorporating earlier detection of cancer into routine medical care. In this capacity, he led the sale of Thrive to Exact Sciences Corp. (Nasdaq: EXAS) for $2.15 billion after rapidly scaling the company and raising $257 million in a Series B financing. Prior to Thrive, Mr. Ro led the U.S. Medical Technology team at Goldman Sachs where he covered the Life Science Tools, Diagnostics and Medical Technology sectors. He also held a similar role at SVB Leerink. His career as an equity analyst spanned 16 years, over 60 publicly traded companies, and numerous IPOs and equity financing transactions.

“Isaac’s highly impressive background and experience make him a perfect fit for the role of CFO at Sema4,” said Eric Schadt, Ph.D., Founder and Chief Executive Officer of Sema4. “His strong expertise in working with publicly traded companies focused on healthcare and technology will be a huge asset to us. I am excited about the strategic contributions Isaac will make to our business and to our mission of advancing healthcare through data-driven insights.”

“I am thrilled to join Sema4 at such an exciting time for the company and the broader life sciences industry,” said Mr. Ro. “We are witnessing the convergence of breakthrough technologies and vast datasets that together are poised to enable health intelligence in unprecedented ways. It is a privilege to join my new colleagues in our collective mission to address this enormous white space.”

About Sema4

Sema4 is a patient-centered health intelligence company founded on the idea that more information, deeper analysis, and increased engagement will improve the diagnosis, treatment, and prevention of disease. Sema4 is dedicated to transforming healthcare by building dynamic models of human health and defining optimal, individualized health trajectories, starting in the areas of reproductive health and oncology. Centrellis™, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.

For more information, please visit and connect with Sema4 on Twitter, LinkedIn, Facebook and YouTube.

Media contact:
Radley Moss